{
  "paper_metadata": {
    "pmid": "22666503",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information including clinical significance, penetrance data, and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1029delA",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "TNBC patients, unselected for age and family history",
        "phenotype": "triple-negative breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 5,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Detected as a deleterious mutation.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in the study population.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Part of the high frequency of BRCA2 mutations observed in the study.",
      "key_quotes": [
        "A high frequency of deleterious germline mutations was observed in BRCA2 (5/30; 16.7%)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6444dupT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "TNBC patients, unselected for age and family history",
        "phenotype": "triple-negative breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 5,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Detected as a deleterious mutation.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in the study population.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Part of the high frequency of BRCA2 mutations observed in the study.",
      "key_quotes": [
        "A high frequency of deleterious germline mutations was observed in BRCA2 (5/30; 16.7%)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.476-1G>A",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "TNBC patients, unselected for age and family history",
        "phenotype": "triple-negative breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 5,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Detected as a deleterious splice-site mutation.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in the study population.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Part of the high frequency of BRCA2 mutations observed in the study.",
      "key_quotes": [
        "A high frequency of deleterious germline mutations was observed in BRCA2 (5/30; 16.7%)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "p.S1882X",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "TNBC patients, unselected for age and family history",
        "phenotype": "triple-negative breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 5,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Detected as a deleterious mutation.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in the study population.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Part of the high frequency of BRCA2 mutations observed in the study.",
      "key_quotes": [
        "A high frequency of deleterious germline mutations was observed in BRCA2 (5/30; 16.7%)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "p.W2626C",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "predictive deleterious",
      "patients": {
        "count": 1,
        "demographics": "TNBC patients, unselected for age and family history",
        "phenotype": "triple-negative breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 5,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Classified as predictive deleterious in prior literature.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in the study population.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Part of the high frequency of BRCA2 mutations observed in the study.",
      "key_quotes": [
        "A high frequency of deleterious germline mutations was observed in BRCA2 (5/30; 16.7%)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 5,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}